Long-term clinical outcomes and analyses of atezolizumab for mTNBC

Prof Schmid presents research from a phase Ia expansion study at AACR 2017, evaluating responses to atezolizumab in patients with metastatic triple negative breast cancer. Slides from this presentation are available here. Prof Schmid discussed these...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2osXMww
via IFTTT